Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank38
3Y CAGR-26.6%
5Y CAGR-16.6%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-26.6%/yr
vs +30.4%/yr prior
5Y CAGR
-16.6%/yr
Recent deceleration
Acceleration
-57.0pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$138.19M-1.2%
2024$139.81M-61.0%
2023$358.60M+2.8%
2022$348.78M-1.7%
2021$354.86M+3.5%
2020$342.94M+158.9%
2019$132.44M+9.9%
2018$120.47M-36.4%
2017$189.52M-30.5%
2016$272.65M-